Influence of Fimasartan (a Novel AT1Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Influence of Fimasartan (a Novel AT1Receptor Blocker) on Catecholamine Release in the Adrenal Medulla of Spontaneously Hypertensive Rats

Published:2013 Issue:1 Volume:17 Page:99
ISSN:1226-4512
Container-title:The Korean Journal of Physiology & Pharmacology
language:en
Short-container-title:Korean J Physiol Pharmacol

Author:

Lim Hyo-Jeong¹,Lee Seog-Ki²,Lim Dong-Yoon³

Affiliation:

1. Department of Internal Medicine, School of Medicine, Seoul National University, Seoul 710-744, Korea.

2. Department of Chest Surgery, College of Medicine, Chosun University, Gwangju 501-759, Korea.

3. Department of Pharmacology, College of Medicine, Chosun University, Gwangju 501-759, Korea.

Publisher

The Korean Physiological Society and The Korean Society of Pharmacology

Subject

Pharmacology,Physiology

Link

https://synapse.koreamed.org/pdf/10.4196/kjpp.2013.17.1.99

Reference71 articles.

1. Fimasartan, a novel angiotensin II receptor antagonist

2. Review: Angiotensin II type 1 receptor blockers: class effects versus molecular effects

3. Drug interactions with angiotensin receptor blockers

4. Efficacy in angiotensin receptor blockade: a comparative review of data with olmesartan

5. Pharmacokinetic Interaction of Fimasartan, a New Angiotensin II Receptor Antagonist, With Amlodipine in Healthy Volunteers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2018-05-04

2. Angiotensin II receptor blockers following intravenous nicardipine administration to lower blood pressure in patients with hypertensive intracerebral hemorrhage;Blood Pressure Monitoring;2017-02

3. Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration;Biological & Pharmaceutical Bulletin;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3